Outpatient Surgery Magazine - Subscribers

Marking Madness - April 2013 edition of Outpatient Surgery Magazine

Outpatient Surgery Magazine, providing current information on Surgical Services, Surgical Facility Administration, Outpatient Surgery News and Trends, OR Excellence and more.

Issue link: http://outpatientsurgery.uberflip.com/i/121493

Contents of this Issue

Navigation

Page 140 of 157

OSM560-April_DIGITAL_rev_Layout 1 4/8/13 11:09 AM Page 141 COMPOUNDING WOES FDA Wants Control Over Compounders and failed to follow his directions. Meanwhile, I pointed out that the tone of his voice made it very difficult for the surgical team to concentrate on proper patient care. Staff often approach me after the role-playing exercises to let me know how much it helped them manage actual difficult situations in the OR. A staff member once told me that an anesthetist had yelled at her in front of the patient during a pre-op time out when she was asked about the antibiotic administration. The nurse said she tried some of the communication tools she learned during roleplaying, and the anesthetist apologized after being approached about the negative behavior. Now the two actually have a better working relationship. T hree more compounding pharmacies, one in New Jersey, one in Georgia and one in Massachusetts, were forced to recall all their compounded products last month as a result of stepped-up FDA inspections. The FDA wants Congress to expand its legal powers over compounding pharmacies and to perhaps charge fees for this oversight. FDA Commissioner Margaret A. Hamburg, MD, believes the agency could ensure that drugs produced by sterile compounders would be compounded "without putting patients at undue risk." To support these activities, funding would be necessary, she says. "[O]ur authorities are limited and not the right fit for FDA to provide appropriate and efficient oversight of this growing industry," Dr. Hamburg writes on the FDA blog. "There should be legislation that establishes appropriate, minimum federal standards for firms that compound sterile drug products in advance of or without a prescription and ship them interstate." The FDA's authority must be made clear because, "[e]ven during this time of heightened awareness, our inspectors are being delayed in their work or denied full access to records at some of the facilities we are inspecting." — Stephanie Wasek A P R I L 2 013 | O U T PAT I E N T S U R G E R Y M A G A Z I N E | 1 4 1

Articles in this issue

Archives of this issue

view archives of Outpatient Surgery Magazine - Subscribers - Marking Madness - April 2013 edition of Outpatient Surgery Magazine